<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><label>Table 2.</label><caption><title>Summary of genetic variation across 151 isolates of the <italic>L. donovani</italic> complex for previously described loci involved in resistance or treatment failure of antimonial drugs and Miltefosine.</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top">locus/complex</th><th colspan="3" valign="top">gene id</th><th rowspan="2" valign="top">gene name</th><th rowspan="2" valign="top">function prediction</th><th rowspan="2" valign="top">involved in resistance (R)/treatment failure (TF) to drug:</th><th rowspan="2" valign="top">reference</th><th rowspan="2" valign="top">evidence from reference</th><th rowspan="2" valign="top">gene copy number (gene CN)</th></tr><tr><th valign="top"><italic>L. infantum</italic>, JPCM5, v41</th><th valign="top"><italic>L. infantum</italic>, JPCM5, v38</th><th valign="top"><italic>L. donovani</italic> ortholog, BPK282A1, v41</th></tr></thead><tbody><tr><td rowspan="5" valign="top">H-locus</td><td valign="top">LINF_230007700</td><td valign="top">LinJ.23.0280</td><td valign="top">LdBPK_230280</td><td valign="top">terbinafine resistance gene (HTBF), (YIP1)</td><td valign="top"/><td valign="top">Antimonials (R)</td><td valign="top"><xref ref-type="bibr" rid="bib22">Callahan and Beverley, 1991</xref>; <break/><xref ref-type="bibr" rid="bib33">Dias et al., 2007</xref></td><td valign="top">The <italic>Leishmania</italic> H region is frequently amplified in drug-resistant lines and is associated with metal resistance (genes YIP1, MRPA, PTR1).</td><td rowspan="5" valign="top">Genes have an increased CN in 30% (CN +1 to +44), and reduced CN in 9% (CN &#8722;1). <break/>37% of all samples have an insertion including at least three genes (always YIP1, MRPA and argininosuccinate synthase). These amplifications are in groups Ldon1 (42/45), Ldon3 (13/19) and Ldon5 (1/8). The insertion boundaries in isolates from groups Ldon1 and Ldon3 are shared (<xref ref-type="fig" rid="fig9s1">Figure 9&#8212;figure supplement 1A</xref>).</td></tr><tr><td valign="top">LINF_230007800</td><td valign="top">LinJ.23.0290</td><td valign="top">LdBPK_230290</td><td valign="top">P-glycoprotein A (MRPA); pentamidine resistance protein 1</td><td valign="top">ATP-binding cassette (ABC) transporter, ABC-thiol transporter</td><td valign="top">Antimonials (R)</td><td valign="top"><xref ref-type="bibr" rid="bib22">Callahan and Beverley, 1991</xref>; <break/><xref ref-type="bibr" rid="bib33">Dias et al., 2007</xref>; <xref ref-type="bibr" rid="bib65">Leprohon et al., 2009</xref></td><td valign="top">Increased expression of MRPA is often due to the amplification of its gene in antimony-resistant strains.</td></tr><tr><td valign="top">LINF_230007900</td><td valign="top">LinJ.23.0300</td><td valign="top">LdBPK_230300</td><td valign="top"/><td valign="top">argininosuccinate synthase - putative</td><td valign="top">Antimonials</td><td valign="top"><xref ref-type="bibr" rid="bib50">Grondin et al., 1993</xref>; <break/><xref ref-type="bibr" rid="bib65">Leprohon et al., 2009</xref></td><td valign="top"/></tr><tr><td rowspan="2" valign="top">LINF_230008000</td><td rowspan="2" valign="top">LinJ.23.0310</td><td rowspan="2" valign="top">LdBPK_230310</td><td rowspan="2" valign="top">Pteridine reductase 1 (PTR1)</td><td rowspan="2" valign="top"/><td valign="top">Antimonials (R)</td><td valign="top"><xref ref-type="bibr" rid="bib22">Callahan and Beverley, 1991</xref>; <break/><xref ref-type="bibr" rid="bib33">Dias et al., 2007</xref></td><td valign="top">see above, evidence only for H-locus in general</td></tr><tr><td valign="top">Antifolate (R)</td><td valign="top"><xref ref-type="bibr" rid="bib123">Vickers and Beverley, 2011</xref></td><td valign="top"><italic>Leishmania</italic> salvage folate from their hosts. Thereby folates are reduced by a DHFR (dihydrofolate reductase)-TS (thymidylate synthase) and PTR1. PTR1 can act as a metabolic bypass of DHFR inhibition, reducing the effectiveness of existing antifolate drugs.</td></tr><tr><td valign="top">Mitogen-activated protein kinase, MAPK1</td><td valign="top">LINF_360076200</td><td valign="top">LinJ.36.6760</td><td valign="top">LdBPK_366760</td><td valign="top">LMPK, mitogen-activated protein kinase</td><td valign="top">protein phosphorylation</td><td valign="top">Antimonials (R)</td><td valign="top"><xref ref-type="bibr" rid="bib105">Singh et al., 2010</xref>; <xref ref-type="bibr" rid="bib13">Ashutosh et al., 2012</xref></td><td valign="top">Conflicting evidence between up- and down-regulation of Mitogen-Activated Protein Kinase one between different studies.</td><td valign="top">45% of all isolates showed an increased CN, with all isolates of Ldon1 andLdon3 being affected and smaller fractions in other <italic>L. donovani</italic> groups (<xref ref-type="fig" rid="fig9s2">Figure 9&#8212;figure supplement 2A</xref>).</td></tr><tr><td valign="top">Aqua-glyceroporin, AQP1</td><td valign="top">LINF_310005100</td><td valign="top">LinJ.31.0030</td><td valign="top">LdBPK_310030</td><td valign="top">Aquaglyceroporin 1, AQP1</td><td valign="top">drug transmembrane transport</td><td valign="top">Antimonials (R)</td><td valign="top"><xref ref-type="bibr" rid="bib48">Gourbal et al., 2004</xref>; <break/><xref ref-type="bibr" rid="bib121">Uzcategui et al., 2008</xref>; <break/><xref ref-type="bibr" rid="bib74">Monte-Neto et al., 2015</xref>; <break/><xref ref-type="bibr" rid="bib10">Andrade et al., 2016</xref>; <break/><xref ref-type="bibr" rid="bib55">Imamura et al., 2016</xref></td><td valign="top">A frequently resistant <italic>L. donovani</italic> population has a two base-pair insertion in AQP1 preventing antimonial transport. <break/>Increased resistance with decrease in gene CN or expression, while increase leads to higher drug sensitivity.</td><td valign="top">Gene CN deletions and insertions of small effect sizes (CN &#8722;2 to &#8722;1 and +1 to +3) are present in 6% and 35% of isolates but never leading to loss of the locus.</td></tr><tr><td rowspan="3" valign="top">Miltefosine transporter and associated genes</td><td valign="top">LINF_130020800</td><td valign="top">LinJ.13.1590</td><td valign="top">LdBPK_131590</td><td valign="top">Miltefosine transporter, LdMT</td><td valign="top">phospholipid transport</td><td valign="top">Miltefosine (R)</td><td valign="top"><xref ref-type="bibr" rid="bib81">P&#233;rez-Victoria et al., 2006</xref>; <break/><xref ref-type="bibr" rid="bib103">Shaw et al., 2016</xref></td><td valign="top">Gene deletion or different changes in two different strains evolved in promastigote culture for Miltefosine resistance. strain Sb-S: locus deletion and A691P; strain Sb-R: E197D</td><td valign="top">15 isolates: +1 gene CNV (CUK, Ldon1, Ldon2, Ldon3, Ldon5)</td></tr><tr><td valign="top">LINF_130020900</td><td valign="top">LinJ.13.1600</td><td valign="top">LdBPK_131600</td><td valign="top">hypothetical protein</td><td valign="top">unknown function</td><td valign="top">Miltefosine (R)</td><td valign="top"><xref ref-type="bibr" rid="bib103">Shaw et al., 2016</xref></td><td valign="top">Deleted along with the Miltefosine transporter gene in a single line evolved for Miltefosine resistance in promastigote culture.</td><td valign="top">three isolates: +1 gene CNV (Ldon1, Linf1)</td></tr><tr><td valign="top">LINF_320015500</td><td valign="top">LinJ.32.1040</td><td valign="top">LdBPK_321040</td><td valign="top">Ros3, LdRos3</td><td valign="top">Vps23 core domain containing protein - putative</td><td valign="top">Miltefosine (R)</td><td valign="top"><xref ref-type="bibr" rid="bib81">P&#233;rez-Victoria et al., 2006</xref></td><td valign="top">Putative subunit of LdMT; LdMT and LdRos3 seem to form part of the same translocation machinery that determines flippase activity and Miltefosine sensitivity in <italic>Leishmania</italic>.</td><td valign="top">one isolate: +1&#160;gene CNV (Ldon1)</td></tr><tr><td rowspan="4" valign="top">Miltefosine sensitivity locus, MSL</td><td valign="top">LINF_310031200</td><td valign="top">LinJ.31.2370</td><td valign="top">LdBPK_312380</td><td valign="top"/><td valign="top">3'-nucleotidase/nuclease - putative</td><td valign="top">Miltefosine (TF)</td><td valign="top"><xref ref-type="bibr" rid="bib24">Carnielli et al., 2018</xref></td><td rowspan="4" valign="top">MSL: a deletion of this locus was associated with Miltefosine treatment failure in Brazil. While the frequency of the MSL was still relatively high in the North-East it was almost absent in the South-East of Brazil, and it was absent in <italic>L.infantum</italic>/<italic>L.donovani</italic> in the Old World.</td><td rowspan="4" valign="top">Genes have a reduced CN in 55% (CN &#8722;1 to &#8722;8) and increased in 4% (CN +1). <break/>Four isolates, show a complete loss of the MSL at identical boundaries: WC, Cha001, HN167 and HN336 (2/4 isolates from Brazil, 2/2 isolates from Honduras). Two isolates show a reduction of all four genes at this locus but with various deletion boundaries: IMT373cl1 (Portugal), CH35 (Cyprus) (<xref ref-type="fig" rid="fig9">Figure 9B</xref>).</td></tr><tr><td valign="top">LINF_310031300</td><td valign="top">LinJ.31.2380</td><td valign="top">LdBPK_312380</td><td valign="top"/><td valign="top">3'-nucleotidase/nuclease - putative</td><td valign="top">Miltefosine (TF)</td><td valign="top"><xref ref-type="bibr" rid="bib24">Carnielli et al., 2018</xref></td></tr><tr><td valign="top">LINF_310031400</td><td valign="top">LinJ.31.2390</td><td valign="top">LdBPK_312390</td><td valign="top"/><td valign="top">helicase-like protein</td><td valign="top">Miltefosine (TF)</td><td valign="top"><xref ref-type="bibr" rid="bib24">Carnielli et al., 2018</xref></td></tr><tr><td valign="top">LINF_310031500</td><td valign="top">LinJ.31.2400</td><td valign="top">LdBPK_312320, LdBPK_312400</td><td valign="top"/><td valign="top">3&#8211;2-trans-enoyl-CoA isomerase - mitochondrial precursor - putative</td><td valign="top">Miltefosine (TF)</td><td valign="top"><xref ref-type="bibr" rid="bib24">Carnielli et al., 2018</xref></td></tr></tbody></table></table-wrap>